ClinicalTrials.Veeva

Menu

Evaluation of the Efficacy of Low-Frequency Repetitive Transcranial Magnetic Stimulation on Unilateral Neglect in Patients With Subacute-Chronic Phase After Ischemic Stroke

A

Ankara City Hospital

Status

Enrolling

Conditions

Neglect, Hemispatial

Treatments

Device: Active Repetitive Transcranial Magnetic Stimulation
Device: Sham Repetitive Transcranial Magnetic Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06223451
10026592

Details and patient eligibility

About

The aim of this study was to randomize stroke patients with unilateral neglect into 2 groups, active and sham groups, and to examine the effects of active inhibitory repetitive transcranial magnetic stimulation on the reduction of neglect symptoms, functional recovery and independence of these patients in activities of daily living.

Full description

Patients diagnosed with ischemic stroke at least 1 month ago, with unilateral neglect, receiving inpatient rehabilitation at stroke clinics, and meeting the study criteria for both genders between the ages of 18-80, will be divided into two groups. A total of 22 stroke patients, informed about the applied treatments and potential risks, and providing written consent, will be randomly assigned to receive either active repetitive transcranial magnetic stimulation (rTMS) combined with conventional rehabilitation (Mirror therapy and Visual scanning training) or sham (imitation) repetitive transcranial magnetic stimulation (rTMS) combined with conventional rehabilitation.

The study will include 22 randomly selected patients with neglect, with 11 planned in the intervention group and 11 in the control group. Patients will receive active rTMS or sham rTMS for a total of 10 sessions, each lasting 20 minutes, alongside conventional rehabilitation over a period of 2 weeks. rTMS applications will be conducted once daily before the daily rehabilitation program.

Enrollment

22 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First-time ischemic stroke
  • Patients at least 1 month after the stroke
  • To be aged between 18 and 80 years old
  • Presence of unilateral neglect
  • No significant cognitive impairment (MMSE > 24 points)
  • Signing an informed consent form indicating willingness to participate in the study

Exclusion criteria

  • Epilepsy, history of seizure
  • Metallic implant in the area of stimulation (cochlear implant, brain pacemaker, drug pump etc.)
  • Presence of cardiac pacemaker
  • Severe general condition disorder or accompanying neurological disease
  • Aphasi
  • Pregnancy
  • Under 18 years of age and over 80 years of age
  • Visual impairment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

22 participants in 2 patient groups

Active repetitive transcranial magnetic stimulation in stroke patients with unilateral neglect.
Active Comparator group
Description:
Inhibitory repetitive transcranial magnetic stimulation will be applied to 11 patients with unilateral neglect due to ischemic stroke under the supervision of a doctor for a total of 10 sessions over 2 weeks with conventional rehabilitation. Each session will last for 20 minutes,total of 1200 pulses, 1 Hz repetitive transcranial manyetic stimulation over the unaffected left posterior parietal cortex.
Treatment:
Device: Active Repetitive Transcranial Magnetic Stimulation
Sham repetitive transcranial magnetic stimulation in stroke patients with unilateral neglect.
Sham Comparator group
Description:
Patients in the sham group will receive sham transcranial magnetic stimulation with sham coil for 20 minutes a day, 10 sessions in total, together with conventional rehabilitation.
Treatment:
Device: Sham Repetitive Transcranial Magnetic Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Ayşenur Mert Kurt, Medical Doctor; Zeynep A Kurtaran, Professor Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems